Astrana Health, Inc. $ASTH Shares Acquired by Vanguard Group Inc.

Key Points

• Vanguard Group Inc. increased its stake in Astrana Health, owning approximately 8.74% of the company after acquiring an additional 213,033 shares in the first quarter.
• Astrana Health reported a 34.7% increase in quarterly revenue to $654.81 million, although it missed earnings expectations with an EPS of $0.19.
• Several hedge funds have significantly increased their holdings in Astrana Health, with a combined 52.77% of the company's stock now owned by institutional investors.

Vanguard Group Inc. lifted its holdings in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 4.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,898,992 shares of the company's stock after buying an additional 213,033 shares during the period. Vanguard Group Inc. owned approximately 8.74% of Astrana Health worth $151,918,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ASTH. Wells Fargo & Company MN increased its position in Astrana Health by 41.5% during the fourth quarter. Wells Fargo & Company MN now owns 22,484 shares of the company's stock worth $709,000 after purchasing an additional 6,596 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Astrana Health by 19.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after purchasing an additional 1,184 shares in the last quarter. Invesco Ltd. grew its holdings in shares of Astrana Health by 6.9% in the fourth quarter. Invesco Ltd. now owns 258,520 shares of the company's stock valued at $8,151,000 after purchasing an additional 16,717 shares in the last quarter. Barclays PLC lifted its stake in Astrana Health by 3.4% in the fourth quarter. Barclays PLC now owns 79,543 shares of the company's stock worth $2,507,000 after acquiring an additional 2,627 shares during the last quarter. Finally, Marshall Wace LLP purchased a new position in Astrana Health in the fourth quarter worth approximately $2,821,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Stock Up 1.2%

Astrana Health stock traded up $0.36 during trading on Tuesday, reaching $30.29. The stock had a trading volume of 261,570 shares, compared to its average volume of 514,714. The stock has a market cap of $1.70 billion, a PE ratio of 59.39, a P/E/G ratio of 0.74 and a beta of 0.85. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52. Astrana Health, Inc. has a 52-week low of $21.20 and a 52-week high of $63.20. The business has a 50 day moving average price of $25.47 and a 200 day moving average price of $28.54.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.17). The company had revenue of $654.81 million for the quarter, compared to analysts' expectations of $639.13 million. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The firm's quarterly revenue was up 34.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.40 EPS. Astrana Health has set its Q3 2025 guidance at EPS. On average, analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.